Matthew Biegler

Stock Analyst at Oppenheimer

(0)
# 4846
Out of 5,441 analysts
101
Total ratings
Success rate
Average return
28 Stocks
Name Action PT Current % Upside Ratings Updated
ACRV Acrivon Therapeutics
Maintains: Outperform
9 8
1.22 555.74% 3 Aug 14, 2025
NRIX Nurix Therapeutics
Reiterates: Outperform
32 30
9.64 211.2% 2 Jul 31, 2025
CTMX CytomX Therapeutics
Initiates Coverage On: Outperform
7
2.31 203.03% 1 Jul 31, 2025
ALLO Allogene Therapeutic...
Maintains: Outperform
10 9
1.03 773.79% 2 May 14, 2025
OLMA Olema Pharmaceutical...
Maintains: Outperform
25 22
4.57 381.4% 6 May 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 12
9.19 30.58% 5 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
8 8
1.99 302.01% 7 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
40 45
6.58 583.89% 5 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
105 115
120.57 -4.62% 1 Dec 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
53 53
22.84 132.05% 5 Oct 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
25 33
10.1 226.73% 6 Sep 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
20 20
1.4 1328.57% 7 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 6 Sep 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
114 125
129.46 -3.45% 5 Jul 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Peer Perform
n/a
n/a n/a 4 Jul 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
16 14
6.35 120.47% 5 May 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Perform
n/a
n/a n/a 1 Apr 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
33 44
64.97 -32.28% 1 Mar 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Perform
n/a
n/a n/a 5 Feb 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Perform
n/a
n/a n/a 2 Feb 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
8 3
n/a n/a 4 Aug 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
1500 450
1.71 26215.79% 5 Aug 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
30
28 7.14% 1 Jun 2, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 3 Dec 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 2 Dec 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
520 360
8.87 3958.62% 1 Nov 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 3 Feb 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
115 105
n/a n/a 3 Jan 21, 2022